Meanwhile, astrocyte-derived EVs from MS patients contained higher levels of the complement components (C1q, C3, C3b/iC3b, C5, C5a, and Factor H) as compared with control samples [92]. This evidence concerns the gene C3 and myeloid sarcoma.